Skip to content
Home
Technology
Company
News
In the News
Press Releases
Contact
Menu
Home
Technology
Company
News
In the News
Press Releases
Contact
Micron Biomedical
News & Press Releases
In The News
BBC Spotlights “Extremely Promising” Micron Biomedical Data Publication in The Lancent
May 1, 2024
Read More
The Telegraph Spotlights Micron Biomedical Data Publication in The Lancent
May 1, 2024
Read More
Newsweek Spotlights Micron Technology as Part of Bill Gates’Plan to Change Vaccines
January 18, 2024
Read More
World Economic Forum Spotlights Micron’s Dissolvable Microneedles and the Opportunity to Increase Vaccine Uptake
November 23, 2023
Read More
Reuters Spotlights Micron’s Progress Toward Mass Production of Its Proprietary Microarray Technology
November 16, 2023
Read More
FiercePharma Spotlights Micron Biomedical’s Progress to Commercializing a Life-Saving “Button”
November 16, 2023
Read More
View All
Press Releases
Micron Biomedical Announces The Lancet Publication of Positive Phase 1/2 Data From First Clinical Trial of Needle-Free Vaccines in Children
May 1, 2024
Read More
Micron Biomedical Appoints Global Health Pioneer and Champion of Vaccine Access, Dr. Seth Berkley, as Scientific Advisor to the CEO
February 27, 2024
Read More
Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles
November 16, 2023
Read More
Micron Biomedical Appoints Brian Bernick, MD as Chairman of Its Board of Directors
August 9, 2023
Read More
Micron Biomedical Announces Positive Measles and Rubella Vaccination Results from First Clinical Trial of Microarray Injection-Free Vaccine Delivery in Children
May 17, 2023
Read More
Micron Biomedical Extends Series A to $17 Million to Bring Needle-Free Drugs and Vaccines to Market
May 10, 2023
Read More
View All